NCT05505149 is a NA clinical trial of physiotherapy in Cerebral Palsy, sponsored by Abant Izzet Baysal University.

Who is sponsoring NCT05505149?

NCT05505149 is sponsored by Abant Izzet Baysal University.

What drugs are being tested in NCT05505149?

Interventions in NCT05505149: physiotherapy.

What condition does NCT05505149 study?

NCT05505149 studies Cerebral Palsy.

Is NCT05505149 still recruiting?

NCT05505149 is currently completed. Last updated 17 August 2022.

Last reviewed 2022-08-17 · How we verify

NCT05505149

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prognosis of Functionality in Cerebral Palsy: A Retrospektif Study

Completed NA Last updated 17 August 2022

What this trial tests

NA trial testing physiotherapy in Cerebral Palsy in 108 participants. Completed in 1 February 2022.

Timeline

1 February 2020

Primary endpoint
1 February 2022

1 February 2022

Quick facts

Lead sponsor	Abant Izzet Baysal University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	108
Start date	1 February 2020
Primary completion	1 February 2022
Estimated completion	1 February 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

physiotherapy — full drug profile →

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →

Sponsor

Abant Izzet Baysal University

Who can join

Adults 6 Months to 18, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To purpose of this study is ;to evaluate prognosis of functionality in children with Cerebral Palsy in different age groups (preschool, school age and adolescence) and predict the progression of motor function according to different functional classification systems in children with CP over a 2 year period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of physiotherapy

Trials testing the same drug.

NCT07373119 — Improving Frailty in Patients With Stable Ischemic Heart Disease · NA · enrolling by invitation
NCT07254273 — Boccia Exercises and Upper Limb Muscle Adaptations in Hemiparetic Individuals · NA · completed
NCT06678139 — The Effect of Physiotherapy on Lower Extremity Function and Gait in Children with Isolated Gastrocnemius Muscle Tightnes · NA · completed
NCT06547723 — MBSR Program and Evaluating Its Effectiveness on Relieving Chronic Pain in the Elderly · NA · enrolling by invitation
NCT06000254 — High Energy Density Pulse Electromagnetic Field for Patients With Adhensive Capsulitis · NA · completed

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Other Abant Izzet Baysal University trials

Trials by the same sponsor.

NCT07374744 — Effect of Interactive Video-Based Self-Management Education in Adults With Type 2 Diabetes · NA · not yet recruiting
NCT07524790 — The Effect of Proprioceptive Neuromuscular Facilitation on Haemodynamic Responses in a Neurological Intensive Care · NA · not yet recruiting
NCT07507721 — Tele-Nursing-Supported Mindfetalness: Anxiety and Prenatal Attachment · NA · not yet recruiting
NCT07509021 — Neuropathic Pain, Catastrophizing, and Adherence in SAIS · recruiting
NCT07535177 — Gas6 and Soluble MerTK in Periodontal Diseases · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05505149 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abant Izzet Baysal University
Last refreshed: 17 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05505149.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing